SlideShare a Scribd company logo
ATHEROSCLEROSIS
ASVD
• Definition
• Atherosclerosis also called
arteriosclerotic vascular disease or ASVD)
1-is a condition in which an artery wall thickens as a result of the
accumulation of fatty materials cholesterol and triglyceride.
2-Also is a syndrome affecting arterial blood vessels,
• a chronic complex inflammatory response in the walls of arteries,
• caused largely by the accumulation of macrophages
(a type white blood cell that ingests blood cell foreign material,
it is key player in the immune response to foreign invaders of the
body) white blood cells promoted by low-density lipoproteins
(LDL, in the Intima plaque of mid and large arteries.
Regarding the plaque ASVD divides in 2 groups
. A-Stable atherosclerosis
• B-unstable (also called vulnerable).
• stable atherosclerotic plaques, which tend to be
asymptomatic, are rich in extracellular matrix and
smooth muscle cells,
• while, unstable plaques are rich in macrophages and
foam cells and the extracellular matrix separating the
lesion from the arterial lumen (also known as the
fibrous cap) is usually weak and prone to rupture
. Ruptures of the fibrous cap expose thrombogenic
material, such as collagen to the circulation and
eventually induce thrombus formation in the
lumen.
• Upon formation, intraluminal thrombi can
occlude arteries outright (e.g. coronary occlusion),
• but more often they detach, move into the
circulation
• eventually occluding smaller downstream
branches causing thrombo embolism.
• The Atheroma ("lump of gruel",(cereal) which
is the nodular accumulation of a soft, flaky,
yellowish material at the center of large
plaques, Underlying areas of cholesterol
crystals Calcification at the outer base of older
• composed of macrophages nearest the lumen
of the artery Atherosclerotic lesions,
• the risk may be higher while in the blood
stream.
• However, LDL particles have a half-life of only
a couple of days and their content (LDL
particles carry cholesterol,
cholesteryl esters(disease) (is a rare genetic
disorder characterized by sub total defect of
an enzyme known as lisosomal acid lipase
(LIPA or LAL)
• Once inside the vessel wall, LDL particles get
stuck and their content becomes more prone
to oxidation.
• Than The damage caused by the oxidized LDL
molecules triggers a cascade of immune
responses which over time can produce an
atheroma.
• The body's immune system responds to the damage to
the artery wall caused by oxidized LDL by sending
specialized white blood cells (macrophages and T-
lymphocytes) to absorb the oxidized-LDL forming
specialized foam cells.
• These white blood cells are not able to process the
oxidized-LDL, and ultimately grow then rupture,
depositing a greater amount of oxidized cholesterol
into the artery wall.
• This triggers more white blood cells, continuing the
cycle.
• Ther 2 type of plaque
• The fibro-lipid (fibro-fatty) plaque is
characterized by an accumulation of lipid-
laden cells underneath the intima of the
arteries,
• The fibrous plaque
• is also localized under the intima, within the
wall of the artery resulting in thickening and
expansion of the wall and, sometimes, spotty
localized narrowing of the lumen with some
atrophy of the muscular layer.
Lipid fraction and the risk of CAD
• Cholesterol is caried primarily 3 defferent
lipoprotien
• The VLDL,LDL,and HDL molecules
• 1- Total cholesterole= HDL+VLDL+LDL
• 2-VLDL cholesterole= Triglyceride/5
• 3-LDL = Total chol-HDL chol-Trigly /5 = mg/dl
SI unit
• 4-LDL= Total chol-HDL chol-Trigly/2 = mmol/l
• mmol/L -mmol/L- Trigly/2.2= mmol/l
• Interestingly, chronically expanding
lesions are often asymptomatic until
lumen stenos is is so severe (usually over
80%) that blood supply to downstream
tissue(s) is insufficient, resulting in
ischemia.
• These complications of advanced
atherosclerosis are chronic, slowly progressive
and cumulative.
• Most commonly, soft plaque suddenly
ruptures , causing the formation of a
thrombus that will rapidly slow or stop blood
flow,
• leading to death of the tissues fed by the
artery in approximately 5 minutes.
• This catastrophic event is called an infarction.
• One of the most common recognized
scenarios is called coronary thrombosis of a
coronary artery emboli ,
• causing myocardial infarction (a heart attack).
• The same process in an artery to the brain is
commonly called stroke.
• Another common scenario in very advanced
disease is claudicating from insufficient blood
supply to the legs, typically caused by a
combination of both stenosis and aneurysm
segments narrowed with clots called
thrombophilibitis .
Atherosclerosis affects
• the entire artery tree, but mostly larger, high-
pressure vessels such as the
• coronary,
• renal,
• femoral,
• cerebral,
• and carotid arteries.
• These are termed "clinically silent" because the
person having the infarction does not notice the
problem and does not seek medical help,
• or when they do, physicians do not recognize
what has happened.
Signs and symptom
• Clinically, atherosclerosis is typically associated with
men over the age of 45y.
• Sub-clinically, the disease begins to appear at early
childhood, and perhaps even at birth.
• Noticeable signs can begin developing at puberty.
• Though symptoms are rarely exhibited in children,
• Early screening of children for cardiovascular
diseases could be beneficial to both the child and
his/her relatives.
• ATheroma in arm, or more often in leg arteries,
which produces decreased blood flow is called
peripheral artery occlusive disease (PAOD).
• While coronary artery disease is more
prevalent in men than women, atherosclerosis
of the cerebral arteries and strokes equally
affect both sexes.
• According to United States data for the year
20013,
• for about 66% of men and 47% of women, the
first symptom of atherosclerotic
cardiovascular disease is heart attack or
sudden cardiac death (death within one hour
of onset of the symptom).
• Most artery flow disrupting events occur at
locations with less than 50% lumen narrowing
• Diagnosis
• Cardiac stress testing,
• traditionally the most commonly performed non-
invasive testing method for blood flow limitations,
in general, detects only lumen narrowing of ~75%
or greater,
• Nuclear STRESS TEST
• Although some physicians claim that nuclear stress
methods can detect as little as 50%.
• A famous case study involved autopsies of
American soldiers killed in World War II and
the Korean War.
• Although these were mostly young, healthy
men in their 20s, many already had
evidence of developing atherosclerosis.
• Other studies done on soldiers in the
Second Indochina War showed similar
results, although often worse than the ones
from the earlier wars.
• Theories include high rates of tobacco use
and (in the case of the Vietnam soldiers),
the advent of processed foods after WWII.
Herpes virus infection of arterial smooth muscle
cells has been shown to cause cholesteryl
ester (CE) accumulation.
Cholesteryl ester accumulation is associated
with atherosclerosis.
Also, cytomegalovirus (CMV) infection is
associated with cardiovascular diseases.
• Risk factors
• Various anatomic and physiological risk factors
for atherosclerosis are known.
• These can be divided into various categories:
• A-Congenital
• B- Acquired,
• C-Modifiable ,
•
• Risks multiply, with two factors increasing the
risk of atherosclerosis fourfold.
• Hyperlipidemia, hypertension and cigarette
smoking together increases the risk seven
times.
• Modifiable Diabetesor Impaired glucose
tolerance (IGT)
• Lesser or uncertainThe following factors are of
relatively lesser importance, are uncertain or
unquantified:
• Obesity - (in particular central obesity, also
referred to as abdominal or male-type obesity) +
• Postmenopausal syndrom estrogen deficiency
• High intake of saturated fat (may raise total and
LDL cholesterol
• Intake of trans fat (may raise total and LDL
cholesterol while lowering HDL cholesterol)(is the
worst type of fat also called unsaturated which
has double carbon means (E-esomer) and fatty
acid (s)
• High carbohydrate intake[
• Elevated serum levels of triglycerides+
• Elevated serum levels of homocysteine(is a
naturally occuring amino acid found in plasma .
• Elevated serum levels of uric acid (also
responsible for gout)
• Elevated serum fibrinogen concentrations(is a
protien produce by the liver –help stop bleeding
–helping blood to create clot
• Elevated serum lipoprotein(a) concentrations[
(contain both protien and lipids allows fat to move
through the water inside and outside the cell
• Chronic systemic inflammation as reflected by
upper normal WBC concentrations, elevated
hs-CRP and many other blood chemistry
markers, most only research level at present,
not clinically done.
• Hyperthyroidism (an over-active thyroid)
• Elevated serum insulin levels +
• Short sleep duration
• Chlamydia pneumoniae infection
• Stenoses can be slowly progressive, whereas
plaque ulceration is a sudden event that
occurs specifically in atheromas with
thinner/weaker fibrous caps that have
become "unstable".
• Examples of anatomical detection methods
include
• (1) coronary calcium scoring by CT,
• (2) carotid IMT (intimal media thickness)
measurement by ultrasound, and
• (3) intravascular ultrasound (IVUS). Examples of
physiologic measurement methods include (1)
lipoprotein subclass analysis,
• (2) HbA1c,
• (3) hs-CRP, and
• (4) homocysteine.
• Screeing of patients –called framingham 10
years CAD risk projection are the standard
• Depend of age of patients gaving special
score.
• Treatment plan
• 1- reduction of LDL and other risk factors
Smoking .hypertension ,dibetis ,alcohole use
,sedentary life style ,non of exercise ,deitary
life style
Pharmacologic therapy
• KEEP LDL less than 100mg/L (2.6 mmol/L) with
asprin 81mg reduce the risk to 10-20%
• 1-Niacin (nicotinic acid ) 3-4,5mg/daily reduce
chance of CHD 15-20% -but cause flushing (hot
flushes ) which reduced the use
• 2-Cholestyramin (Bile Acid-Binding resins )
reduce the risk 20%- unfortunately increased
triglyceride to be careful
3-Statin- Hydroxymethylglutaryl
A (HMG-COA)reductase inhibitors
Include atorvastatin –fluvastatin-lovastain-pitavastatin-
pravstatin –rosuvastatin- and simivastatin they reduce
the enzymes which creating cholesterole.
Reduce MI-STROKE,
Atrovastatin 10-40mg/d
Rosuvastatin5-40mg/d
Fluvastatin 20-40mg/d
Pravastatin 10-40mg/d
Simvastatin 5-40mg/d
Side effect muscle aches-GI effect-livetr effect myositis
and rhabdomyolysis
D-Fibric Acid derivative
• Reduce LDL –and plasma triglycerid 10 to 15%
• Include gemfebrozil-600mg once or twice daily
• Ciprofibrate and bezafibrate
• Side effect are include
chlelithithisis,hepatitis,myosistis reduce the
use now
E- Ezitimibe
Reduce the absorbtion of dietary cholesterole in
intestine -10-15mg/d have les side effect
• Best with low risk medication are
• 1-HMG-COA statines better to use with low
dose
• 2-Niacine can be used with combination must
be carefull
• 3-Resins (cholestyramin ) is safe during
pregnancy
• 4-combination of those medication would
creating side effects on liver –GI and musles

More Related Content

Similar to atherosclerosis.pptx

Coronary artery diseases
Coronary artery diseasesCoronary artery diseases
Coronary artery diseases
Denis Katatwire
 
Metabolic basis of Atherosclerosis; Biochemistry - February 2015
Metabolic basis of Atherosclerosis; Biochemistry - February 2015Metabolic basis of Atherosclerosis; Biochemistry - February 2015
Metabolic basis of Atherosclerosis; Biochemistry - February 2015
Kareem Alnakeeb
 
Pathology of blood vessels
Pathology of blood vesselsPathology of blood vessels
Pathology of blood vessels
martin osodo
 
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
utsav parmar
 
ATHEROSCLEROSIS pathophysiology .pptx
ATHEROSCLEROSIS pathophysiology    .pptxATHEROSCLEROSIS pathophysiology    .pptx
ATHEROSCLEROSIS pathophysiology .pptx
Imtiyaz60
 
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
Mahendar S
 
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
Kamalesh Lenka
 
ARTERIOSC.pptx
ARTERIOSC.pptxARTERIOSC.pptx
ARTERIOSC.pptx
HanaaMohamedSheikhOm
 
ARTERIOSC.pptx
ARTERIOSC.pptxARTERIOSC.pptx
ARTERIOSC.pptx
HanaaMohamedSheikhOm
 
IHD .pptx
IHD .pptxIHD .pptx
IHD .pptx
9459654457
 
Chd edexcel
Chd edexcelChd edexcel
Chd edexcel
Rachael Passant-Coy
 
CARDIACMYOPATHY.pptx
CARDIACMYOPATHY.pptxCARDIACMYOPATHY.pptx
CARDIACMYOPATHY.pptx
anandkumargond2
 
Pharmacotherapy of Atherosclerosis
Pharmacotherapy of AtherosclerosisPharmacotherapy of Atherosclerosis
Pharmacotherapy of Atherosclerosis
Koppala RVS Chaitanya
 
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
SHRUTHI VASAN
 
Ischaemic heart disease.pptx
Ischaemic heart disease.pptxIschaemic heart disease.pptx
Ischaemic heart disease.pptx
Imtiyaz60
 
Myocarditis & Cardiomyopathy.pptx
Myocarditis & Cardiomyopathy.pptxMyocarditis & Cardiomyopathy.pptx
Myocarditis & Cardiomyopathy.pptx
Asokan R
 
ARTERIOSCLEROSIS.pptx
ARTERIOSCLEROSIS.pptxARTERIOSCLEROSIS.pptx
ARTERIOSCLEROSIS.pptx
SAMOEINESH
 
2.9. Atherosclerosis.ppt
2.9. Atherosclerosis.ppt2.9. Atherosclerosis.ppt
2.9. Atherosclerosis.ppt
AmareDejene
 
systemic sclerosis and scleroderma powerpoint
systemic sclerosis and scleroderma powerpointsystemic sclerosis and scleroderma powerpoint
systemic sclerosis and scleroderma powerpoint
7543e80ceb
 
MANAGEMENT OF MEDICALLY COMPROMISED PATIENTS- CARDIO-VASCULAR DISEASES ISCHE...
MANAGEMENT OF MEDICALLY COMPROMISED PATIENTS-CARDIO-VASCULAR DISEASES ISCHE...MANAGEMENT OF MEDICALLY COMPROMISED PATIENTS-CARDIO-VASCULAR DISEASES ISCHE...
MANAGEMENT OF MEDICALLY COMPROMISED PATIENTS- CARDIO-VASCULAR DISEASES ISCHE...
Shankar Hemam
 

Similar to atherosclerosis.pptx (20)

Coronary artery diseases
Coronary artery diseasesCoronary artery diseases
Coronary artery diseases
 
Metabolic basis of Atherosclerosis; Biochemistry - February 2015
Metabolic basis of Atherosclerosis; Biochemistry - February 2015Metabolic basis of Atherosclerosis; Biochemistry - February 2015
Metabolic basis of Atherosclerosis; Biochemistry - February 2015
 
Pathology of blood vessels
Pathology of blood vesselsPathology of blood vessels
Pathology of blood vessels
 
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
 
ATHEROSCLEROSIS pathophysiology .pptx
ATHEROSCLEROSIS pathophysiology    .pptxATHEROSCLEROSIS pathophysiology    .pptx
ATHEROSCLEROSIS pathophysiology .pptx
 
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
 
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
 
ARTERIOSC.pptx
ARTERIOSC.pptxARTERIOSC.pptx
ARTERIOSC.pptx
 
ARTERIOSC.pptx
ARTERIOSC.pptxARTERIOSC.pptx
ARTERIOSC.pptx
 
IHD .pptx
IHD .pptxIHD .pptx
IHD .pptx
 
Chd edexcel
Chd edexcelChd edexcel
Chd edexcel
 
CARDIACMYOPATHY.pptx
CARDIACMYOPATHY.pptxCARDIACMYOPATHY.pptx
CARDIACMYOPATHY.pptx
 
Pharmacotherapy of Atherosclerosis
Pharmacotherapy of AtherosclerosisPharmacotherapy of Atherosclerosis
Pharmacotherapy of Atherosclerosis
 
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
 
Ischaemic heart disease.pptx
Ischaemic heart disease.pptxIschaemic heart disease.pptx
Ischaemic heart disease.pptx
 
Myocarditis & Cardiomyopathy.pptx
Myocarditis & Cardiomyopathy.pptxMyocarditis & Cardiomyopathy.pptx
Myocarditis & Cardiomyopathy.pptx
 
ARTERIOSCLEROSIS.pptx
ARTERIOSCLEROSIS.pptxARTERIOSCLEROSIS.pptx
ARTERIOSCLEROSIS.pptx
 
2.9. Atherosclerosis.ppt
2.9. Atherosclerosis.ppt2.9. Atherosclerosis.ppt
2.9. Atherosclerosis.ppt
 
systemic sclerosis and scleroderma powerpoint
systemic sclerosis and scleroderma powerpointsystemic sclerosis and scleroderma powerpoint
systemic sclerosis and scleroderma powerpoint
 
MANAGEMENT OF MEDICALLY COMPROMISED PATIENTS- CARDIO-VASCULAR DISEASES ISCHE...
MANAGEMENT OF MEDICALLY COMPROMISED PATIENTS-CARDIO-VASCULAR DISEASES ISCHE...MANAGEMENT OF MEDICALLY COMPROMISED PATIENTS-CARDIO-VASCULAR DISEASES ISCHE...
MANAGEMENT OF MEDICALLY COMPROMISED PATIENTS- CARDIO-VASCULAR DISEASES ISCHE...
 

Recently uploaded

Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Tina Purnat
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
19various
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
SwisschemDerma
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
bkling
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
SwisschemDerma
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Oleg Kshivets
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
FFragrant
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
Swastik Ayurveda
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
KafrELShiekh University
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
suvadeepdas911
 

Recently uploaded (20)

Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
 

atherosclerosis.pptx

  • 2. ASVD • Definition • Atherosclerosis also called arteriosclerotic vascular disease or ASVD) 1-is a condition in which an artery wall thickens as a result of the accumulation of fatty materials cholesterol and triglyceride. 2-Also is a syndrome affecting arterial blood vessels, • a chronic complex inflammatory response in the walls of arteries, • caused largely by the accumulation of macrophages (a type white blood cell that ingests blood cell foreign material, it is key player in the immune response to foreign invaders of the body) white blood cells promoted by low-density lipoproteins (LDL, in the Intima plaque of mid and large arteries.
  • 3. Regarding the plaque ASVD divides in 2 groups . A-Stable atherosclerosis • B-unstable (also called vulnerable). • stable atherosclerotic plaques, which tend to be asymptomatic, are rich in extracellular matrix and smooth muscle cells, • while, unstable plaques are rich in macrophages and foam cells and the extracellular matrix separating the lesion from the arterial lumen (also known as the fibrous cap) is usually weak and prone to rupture
  • 4. . Ruptures of the fibrous cap expose thrombogenic material, such as collagen to the circulation and eventually induce thrombus formation in the lumen. • Upon formation, intraluminal thrombi can occlude arteries outright (e.g. coronary occlusion), • but more often they detach, move into the circulation • eventually occluding smaller downstream branches causing thrombo embolism.
  • 5. • The Atheroma ("lump of gruel",(cereal) which is the nodular accumulation of a soft, flaky, yellowish material at the center of large plaques, Underlying areas of cholesterol crystals Calcification at the outer base of older • composed of macrophages nearest the lumen of the artery Atherosclerotic lesions,
  • 6. • the risk may be higher while in the blood stream. • However, LDL particles have a half-life of only a couple of days and their content (LDL particles carry cholesterol, cholesteryl esters(disease) (is a rare genetic disorder characterized by sub total defect of an enzyme known as lisosomal acid lipase (LIPA or LAL)
  • 7. • Once inside the vessel wall, LDL particles get stuck and their content becomes more prone to oxidation. • Than The damage caused by the oxidized LDL molecules triggers a cascade of immune responses which over time can produce an atheroma.
  • 8. • The body's immune system responds to the damage to the artery wall caused by oxidized LDL by sending specialized white blood cells (macrophages and T- lymphocytes) to absorb the oxidized-LDL forming specialized foam cells. • These white blood cells are not able to process the oxidized-LDL, and ultimately grow then rupture, depositing a greater amount of oxidized cholesterol into the artery wall. • This triggers more white blood cells, continuing the cycle.
  • 9. • Ther 2 type of plaque • The fibro-lipid (fibro-fatty) plaque is characterized by an accumulation of lipid- laden cells underneath the intima of the arteries, • The fibrous plaque • is also localized under the intima, within the wall of the artery resulting in thickening and expansion of the wall and, sometimes, spotty localized narrowing of the lumen with some atrophy of the muscular layer.
  • 10. Lipid fraction and the risk of CAD • Cholesterol is caried primarily 3 defferent lipoprotien • The VLDL,LDL,and HDL molecules • 1- Total cholesterole= HDL+VLDL+LDL • 2-VLDL cholesterole= Triglyceride/5 • 3-LDL = Total chol-HDL chol-Trigly /5 = mg/dl SI unit • 4-LDL= Total chol-HDL chol-Trigly/2 = mmol/l • mmol/L -mmol/L- Trigly/2.2= mmol/l
  • 11. • Interestingly, chronically expanding lesions are often asymptomatic until lumen stenos is is so severe (usually over 80%) that blood supply to downstream tissue(s) is insufficient, resulting in ischemia.
  • 12. • These complications of advanced atherosclerosis are chronic, slowly progressive and cumulative. • Most commonly, soft plaque suddenly ruptures , causing the formation of a thrombus that will rapidly slow or stop blood flow, • leading to death of the tissues fed by the artery in approximately 5 minutes. • This catastrophic event is called an infarction.
  • 13. • One of the most common recognized scenarios is called coronary thrombosis of a coronary artery emboli , • causing myocardial infarction (a heart attack). • The same process in an artery to the brain is commonly called stroke. • Another common scenario in very advanced disease is claudicating from insufficient blood supply to the legs, typically caused by a combination of both stenosis and aneurysm segments narrowed with clots called thrombophilibitis .
  • 14. Atherosclerosis affects • the entire artery tree, but mostly larger, high- pressure vessels such as the • coronary, • renal, • femoral, • cerebral, • and carotid arteries. • These are termed "clinically silent" because the person having the infarction does not notice the problem and does not seek medical help, • or when they do, physicians do not recognize what has happened.
  • 15. Signs and symptom • Clinically, atherosclerosis is typically associated with men over the age of 45y. • Sub-clinically, the disease begins to appear at early childhood, and perhaps even at birth. • Noticeable signs can begin developing at puberty. • Though symptoms are rarely exhibited in children, • Early screening of children for cardiovascular diseases could be beneficial to both the child and his/her relatives. • ATheroma in arm, or more often in leg arteries, which produces decreased blood flow is called peripheral artery occlusive disease (PAOD).
  • 16. • While coronary artery disease is more prevalent in men than women, atherosclerosis of the cerebral arteries and strokes equally affect both sexes. • According to United States data for the year 20013, • for about 66% of men and 47% of women, the first symptom of atherosclerotic cardiovascular disease is heart attack or sudden cardiac death (death within one hour of onset of the symptom).
  • 17. • Most artery flow disrupting events occur at locations with less than 50% lumen narrowing • Diagnosis • Cardiac stress testing, • traditionally the most commonly performed non- invasive testing method for blood flow limitations, in general, detects only lumen narrowing of ~75% or greater, • Nuclear STRESS TEST • Although some physicians claim that nuclear stress methods can detect as little as 50%.
  • 18. • A famous case study involved autopsies of American soldiers killed in World War II and the Korean War. • Although these were mostly young, healthy men in their 20s, many already had evidence of developing atherosclerosis. • Other studies done on soldiers in the Second Indochina War showed similar results, although often worse than the ones from the earlier wars. • Theories include high rates of tobacco use and (in the case of the Vietnam soldiers), the advent of processed foods after WWII.
  • 19. Herpes virus infection of arterial smooth muscle cells has been shown to cause cholesteryl ester (CE) accumulation. Cholesteryl ester accumulation is associated with atherosclerosis. Also, cytomegalovirus (CMV) infection is associated with cardiovascular diseases.
  • 20. • Risk factors • Various anatomic and physiological risk factors for atherosclerosis are known. • These can be divided into various categories: • A-Congenital • B- Acquired, • C-Modifiable , •
  • 21. • Risks multiply, with two factors increasing the risk of atherosclerosis fourfold. • Hyperlipidemia, hypertension and cigarette smoking together increases the risk seven times. • Modifiable Diabetesor Impaired glucose tolerance (IGT)
  • 22. • Lesser or uncertainThe following factors are of relatively lesser importance, are uncertain or unquantified: • Obesity - (in particular central obesity, also referred to as abdominal or male-type obesity) + • Postmenopausal syndrom estrogen deficiency • High intake of saturated fat (may raise total and LDL cholesterol • Intake of trans fat (may raise total and LDL cholesterol while lowering HDL cholesterol)(is the worst type of fat also called unsaturated which has double carbon means (E-esomer) and fatty acid (s)
  • 23. • High carbohydrate intake[ • Elevated serum levels of triglycerides+ • Elevated serum levels of homocysteine(is a naturally occuring amino acid found in plasma . • Elevated serum levels of uric acid (also responsible for gout) • Elevated serum fibrinogen concentrations(is a protien produce by the liver –help stop bleeding –helping blood to create clot • Elevated serum lipoprotein(a) concentrations[ (contain both protien and lipids allows fat to move through the water inside and outside the cell
  • 24. • Chronic systemic inflammation as reflected by upper normal WBC concentrations, elevated hs-CRP and many other blood chemistry markers, most only research level at present, not clinically done. • Hyperthyroidism (an over-active thyroid) • Elevated serum insulin levels + • Short sleep duration • Chlamydia pneumoniae infection
  • 25. • Stenoses can be slowly progressive, whereas plaque ulceration is a sudden event that occurs specifically in atheromas with thinner/weaker fibrous caps that have become "unstable".
  • 26. • Examples of anatomical detection methods include • (1) coronary calcium scoring by CT, • (2) carotid IMT (intimal media thickness) measurement by ultrasound, and • (3) intravascular ultrasound (IVUS). Examples of physiologic measurement methods include (1) lipoprotein subclass analysis, • (2) HbA1c, • (3) hs-CRP, and • (4) homocysteine.
  • 27. • Screeing of patients –called framingham 10 years CAD risk projection are the standard • Depend of age of patients gaving special score. • Treatment plan • 1- reduction of LDL and other risk factors Smoking .hypertension ,dibetis ,alcohole use ,sedentary life style ,non of exercise ,deitary life style
  • 28. Pharmacologic therapy • KEEP LDL less than 100mg/L (2.6 mmol/L) with asprin 81mg reduce the risk to 10-20% • 1-Niacin (nicotinic acid ) 3-4,5mg/daily reduce chance of CHD 15-20% -but cause flushing (hot flushes ) which reduced the use • 2-Cholestyramin (Bile Acid-Binding resins ) reduce the risk 20%- unfortunately increased triglyceride to be careful
  • 29. 3-Statin- Hydroxymethylglutaryl A (HMG-COA)reductase inhibitors Include atorvastatin –fluvastatin-lovastain-pitavastatin- pravstatin –rosuvastatin- and simivastatin they reduce the enzymes which creating cholesterole. Reduce MI-STROKE, Atrovastatin 10-40mg/d Rosuvastatin5-40mg/d Fluvastatin 20-40mg/d Pravastatin 10-40mg/d Simvastatin 5-40mg/d Side effect muscle aches-GI effect-livetr effect myositis and rhabdomyolysis
  • 30. D-Fibric Acid derivative • Reduce LDL –and plasma triglycerid 10 to 15% • Include gemfebrozil-600mg once or twice daily • Ciprofibrate and bezafibrate • Side effect are include chlelithithisis,hepatitis,myosistis reduce the use now E- Ezitimibe Reduce the absorbtion of dietary cholesterole in intestine -10-15mg/d have les side effect
  • 31. • Best with low risk medication are • 1-HMG-COA statines better to use with low dose • 2-Niacine can be used with combination must be carefull • 3-Resins (cholestyramin ) is safe during pregnancy • 4-combination of those medication would creating side effects on liver –GI and musles